ROVI — Laboratorios Farmaceuticos Rovi Share News
0.000.00%
Last trade - 00:00- €2.95bn
- €2.94bn
- €743.48m
Rovi says schizophrenia drug will not be launched in US, shares drop
Spanish stocks - Factors to watch on Nov 7
Brief: Rovi Sees 2024 Operating Revenue To Decrease By Mid-Single-Digit Percentage Vs 2023
Brief: ROVI 9M Revenue EUR 564.6 Million
Spanish drugmaker Rovi to keep third-party manufacturing business
Rovi's shares drop after completion of unit's review
Spanish stocks - Factors to watch on Oct. 24 (updated)
Brief: Rovi Completes Strategic Review Of Its CDMO Business
Exane ups Rovi to 'outperform', updates mid-cap top picks
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Rovi slips as CVC is said to be only suitor left for its manufacturing business
CVC in talks to buy stake in Rovi's manufacturing business, Expansion reports
Spanish stocks - Factors to watch on Sept 10
Spanish stocks - Factors to watch on Aug 1
Brief: Rovi To Proceed With Share Capital Reduction
Brief: Rovi Sees 2024 Revenue To Decrease By Mid-Single-Digit Percentage Vs 2023
Brief: ROVI H1 Revenue EUR 329.3 Million
Brief: Rovi H1 Net Profit Down At 44.3 Mln Euros YoY